triazoles has been researched along with Glioma in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 17 (58.62) | 24.3611 |
| 2020's | 5 (17.24) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, KG; Agar, NYR; Asara, JM; Bird, CE; Bonal, DM; Buehler, J; Cahill, DP; Cameron, AB; Dang, T; DeBerardinis, RJ; Endress, JE; Evans, L; Gao, W; Gattie, LC; Gradl, S; Guo, L; Harris, IS; Huang, B; Janzer, A; Jeffers, M; Jennings, RB; Kaelin, WG; Khanal, J; Kornblum, HI; Lee, JH; Lee, S; Lehrman, MA; Levitt, MM; Ligon, KL; Lin, YF; Looper, RE; Losman, JA; Ly, P; Mak, TW; Martin-Sandoval, MS; Mathews, TP; McBrayer, SK; Nguyen, QD; Puliyappadamba, VT; Regan, MS; Richardson, TE; Savani, MR; Shi, DD; Signoretti, S; Stopka, SA; Sutter, A; Wang, AC; Xiao, Y; Xu, L; Xu, M; Zacharias, LG | 1 |
| Abid, S; Ayed-Boussema, I; Hamdi, H; Rjiba-Touati, K | 1 |
| Chen, X; Guo, B; Li, Y; Liang, H; Wang, D; Wang, Q; Wen, N; Xu, L; Zhang, L; Zhang, S; Zheng, H | 1 |
| Funck-Brentano, E; Nilsson, JA; Nilsson, LM; Vizlin-Hodzic, D | 1 |
| Carcaboso, AM; Diederichs, C; Gielen, GH; Hamdan, FH; Hulleman, E; Johnsen, SA; Kramm, CM; Kubiak, K; Nussbaumer, G; Wiese, M | 1 |
| Ang, BT; Cheng, HS; Chong, YK; Law, CLD; Low, ZYJ; Marvalim, C; Tan, NS; Tang, C; Zhu, P | 1 |
| Bianchetti, E; Halatsch, ME; Ishida, CT; Karpel-Massler, G; Shu, C; Siegelin, MD; Westhoff, MA | 1 |
| Hulleman, E; Li, M; Liu, F; Ma, J; Meng, W; Monje, M; Nagaraja, S; Ponnuswami, A; Sun, W; Swigut, T; Tang, Y; Taylor, KR; Vitanza, NA; Woo, PJ; Wysocka, J; Zhang, L | 1 |
| Alsheikh, H; Bastola, S; Chen, Z; Chhipa, R; DasGupta, B; Furuta, T; Gibson, JT; Hambardzumyan, D; Kang, KD; Kim, SH; Komarova, S; Lee, LJ; Lu, S; Lu, X; Minata, M; Nabors, B; Nakada, M; Nakano, I; Newell, EW; Norian, LA; Sabit, H; Sadahiro, H; Shi, J; Simoni, Y; Wang, J; Yamaguchi, S; Yu, H; Zhang, S | 1 |
| Balkanska-Sinclair, E; Floyd, SR; Hammond, PT; Hwang, MK; Lam, FC; Maffa, A; Morton, SW; Vu Han, TL; Wyckoff, J; Yaffe, MB | 1 |
| Allam, M; Babu, PP; Bhavani, AKD; Mudiraj, A; Ranjan, N; Thippana, M | 1 |
| Abid-Essefi, S; Eyer, J; Hamdi, H | 1 |
| Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D | 1 |
| Dave, N; Desai, PB; Gudelsky, GA | 1 |
| Korytova, LI; Masliukova, EA; Meshechkin, AV; Sokurenko, VP; Zhabina, RM | 1 |
| Beert, E; Bradner, J; Brems, H; Cichowski, K; Clapp, W; De Raedt, T; Helin, K; Hornick, JL; Kehrer-Sawatzki, H; Legius, E; Luscan, A; Mautner, V; Ortonne, N; Pasmant, E; Upadhyaya, M; Vidaud, M | 1 |
| Kimura, I; Nishigori, K; Ono, M; Onoe, S; Saji, H; Sampei, S; Temma, T | 1 |
| Chow, LM; Dave, N; Desai, PB; Gudelsky, GA; LaSance, K; Qi, X | 1 |
| An, Q; Birt, M; Hafizi, S; Pilkington, GJ; Vouri, M | 1 |
| Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
| Ahmad, F; Dixit, D; Ghildiyal, R; Joshi, SD; Sen, E | 1 |
| Abshiru, NA; Bartom, ET; Hashizume, R; Horbinski, CM; James, CD; Kelleher, NL; Lulla, RR; Ma, Q; Marshall, SA; Misharin, AV; Morgan, MA; Piunti, A; Rendleman, EJ; Saratsis, AM; Shilatifard, A; Takahashi, YH; Woodfin, AR | 1 |
| Aloisi, AM; Ceccarelli, I; Maddalena, M; Rossi, A; Weber, E | 1 |
| Albasanz, JL; Castillo, CA; Fernández, M; Martín, M | 1 |
| Battastini, AM; Bavaresco, L; Bernardi, A; Delgado-Cañedo, A; Jacques-Silva, MC; Lenz, G; Wink, MR | 1 |
| Benovic, JL; Kelly, E; Parent, JL; Willets, JM | 1 |
| Palmer, TM; Stiles, GL | 1 |
| Divine, G; Ge, S; Mikkelsen, T; Rempel, SA | 1 |
| Franklin, TJ; Twose, PA | 1 |
29 other study(ies) available for triazoles and Glioma
| Article | Year |
|---|---|
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma.
Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioma; Isocitrate Dehydrogenase; Leukemia; Mice; Mutation; Pyrimidines; Salicylanilides; Triazoles | 2022 |
Genotoxic damage and apoptosis in rat glioma (F98) cell line following exposure to bromuconazole.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; DNA Damage; Glioma; Humans; Rats; Triazoles | 2023 |
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.
Topics: Animals; Azepines; Brain Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; Mice; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Transcription Factors; Triazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2019 |
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.
Topics: Acetamides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioma; Humans; Mice; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Rats; Transcription Factors; Triazoles | 2021 |
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.
Topics: Acetylation; Astrocytoma; Azepines; Brain Stem Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; CREB-Binding Protein; Diffuse Intrinsic Pontine Glioma; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Mutation; Nuclear Proteins; Nucleosomes; Proteins; Pyrimidinones; Transcription Factors; Transcriptional Activation; Triazoles | 2020 |
Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation.
Topics: Animals; Antioxidants; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Glioma; Humans; Hypoxia; Male; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-met; Pyrazines; Pyrrolidinones; Quinolines; Signal Transduction; Temozolomide; Transcriptome; Triazoles | 2021 |
BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma.
Topics: Acetanilides; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Azepines; Bcl-2-Like Protein 11; Caspases; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioma; Heterocyclic Compounds, 3-Ring; Humans; Membrane Potential, Mitochondrial; Mice; Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Sulfonamides; Triazoles; Xenograft Model Antitumor Assays | 2017 |
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Brain Stem Neoplasms; Cell Cycle Proteins; Cell Proliferation; Chromatin Assembly and Disassembly; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioma; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Indoles; Male; Mice, Inbred NOD; Mice, SCID; Mutation; Nuclear Proteins; Panobinostat; Phenylenediamines; Primary Cell Culture; Protein Kinase Inhibitors; Pyrimidines; Receptors, Eph Family; RNA Interference; Signal Transduction; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.
Topics: Animals; Apoptosis; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Glioblastoma; Glioma; Humans; Male; Mice; Middle Aged; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Azepines; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Temozolomide; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Glioma; Humans; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidinones; Rats; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Triazoles | 2018 |
Cytotoxic and genotoxic effects of epoxiconazole on F98 glioma cells.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Environmental Pollutants; Epoxy Compounds; Glioma; Humans; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Triazoles | 2019 |
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine | 2013 |
The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
Topics: Algorithms; Animals; Antineoplastic Agents; Area Under Curve; Brain; Brain Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Extracellular Fluid; Female; Glioma; Humans; Letrozole; Microdialysis; Neoplasm Transplantation; Nitriles; Protein Binding; Rats; Rats, Sprague-Dawley; Triazoles | 2013 |
[Effectiveness of the correction of hepatotoxicity during combined chemoradiotherapy for cancer patients].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Drug Administration Schedule; Female; Glioma; Humans; Infusions, Intravenous; Liver; Male; Middle Aged; Neoplasms; Protective Agents; Severity of Illness Index; Treatment Outcome; Triazoles | 2013 |
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.
Topics: Animals; Azepines; Cell Cycle Proteins; Cell Death; Chromatin; Disease Models, Animal; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioma; Humans; Melanoma; Mice; Mitogen-Activated Protein Kinase Kinases; Neoplasm Proteins; Neoplasms; Nerve Sheath Neoplasms; Neurofibromin 1; Nuclear Proteins; Polycomb Repressive Complex 2; ras Proteins; Transcription Factors; Transcription, Genetic; Triazoles; Tumor Suppressor Proteins | 2014 |
Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.
Topics: 3T3-L1 Cells; Animals; Cell Line, Tumor; Drug Design; Fatty Acid-Binding Proteins; Fluorine Radioisotopes; Glioma; Male; Mice; Naphthalenes; Permeability; Positron-Emission Tomography; Radiochemistry; Rats; Tissue Distribution; Triazoles | 2015 |
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation; Female; Gene Expression; Glioma; Humans; Letrozole; Nitriles; Positron-Emission Tomography; Rats; Triazoles; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
Topics: Adult; Apoptosis; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Glioma; Humans; Immunoenzyme Techniques; Intercellular Signaling Peptides and Proteins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptor Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 2015 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Brain Neoplasms; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Cyclic AMP Response Element-Binding Protein; Glioma; Glucose; Humans; Mice, Nude; Phenotype; Phosphorylation; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Messenger; Signal Transduction; Sirtuin 1; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
Topics: Acetylation; Animals; Azepines; Brain Stem Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenomics; Gene Expression Regulation, Neoplastic; Glioma; Histone Code; Histones; Humans; Methylation; Mice; Molecular Targeted Therapy; Mutation; Neurogenesis; Nucleosomes; Polycomb Repressive Complex 2; Protein Transport; RNA-Binding Proteins; Triazoles; Xenograft Model Antitumor Assays | 2017 |
Effects of morphine on testosterone levels in rat C6 glioma cells: modulation by anastrozole.
Topics: Anastrozole; Animals; Cell Line, Tumor; Glioma; Morphine; Nitriles; Rats; Testosterone; Triazoles | 2009 |
Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.
Topics: Adenylyl Cyclases; Animals; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Membrane; Fluorescent Antibody Technique; Glioma; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Molecular Sequence Data; Nerve Tissue Proteins; Protein Binding; Rats; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Adenosine A2; Reverse Transcriptase Polymerase Chain Reaction; Triazines; Triazoles; Xanthines | 2007 |
Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines.
Topics: 5'-Nucleotidase; Actins; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Gene Expression Regulation, Enzymologic; Glioma; Humans; Indomethacin; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Time Factors; Triazoles; Xanthines | 2007 |
Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression.
Topics: Animals; beta-Adrenergic Receptor Kinases; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA, Antisense; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 3; Gene Expression; Glioma; Homeostasis; Hybrid Cells; Mice; Neuroblastoma; Phosphorylation; Rats; Receptors, Purinergic P1; Transfection; Triazines; Triazoles; Tumor Cells, Cultured | 1999 |
Stimulation of A(2A) adenosine receptor phosphorylation by protein kinase C activation: evidence for regulation by multiple protein kinase C isoforms.
Topics: Acetophenones; Animals; Benzopyrans; Carbazoles; CHO Cells; Consensus Sequence; Cricetinae; Cyclic AMP; Dogs; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Glioma; Indoles; Isoenzymes; Maleimides; Mutagenesis, Site-Directed; Phosphorylation; Protein Kinase C; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Signal Transduction; Tetradecanoylphorbol Acetate; Triazines; Triazoles; Tumor Cells, Cultured | 1999 |
Carboxyamido-triazole induces apoptosis in bovine aortic endothelial and human glioma cells.
Topics: Animals; Aorta; Apoptosis; Calcium Channel Blockers; Cattle; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Endothelium, Vascular; Flow Cytometry; Glioma; Humans; In Situ Nick-End Labeling; Time Factors; Triazoles; Tumor Cells, Cultured | 2000 |
Desensitization of beta receptor mediated cyclic AMP response of cultured fibroblasts by partial agonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cells, Cultured; Cyclic AMP; Fibroblasts; Glioma; Humans; Isoproterenol; Kinetics; Phosphodiesterase Inhibitors; Propanolamines; Propranolol; Pyrimidines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Triazoles | 1979 |